NEKTAR THERAPEUTICS (NKTR) › EPS (Diluted)NEKTAR THERAPEUTICS (NKTR) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2016: $-1.102017: $-0.622018: $3.782019: $-2.522020: $-2.492021: $-2.862022: $-1.972023: $-1.452024: $-8.682025: $-9.73$-9.732016EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-9.73-12.1%2024$-8.68-498.6%2023$-1.45+26.4%2022$-1.97+31.1%2021$-2.86-14.9%2020$-2.49+1.2%2019$-2.52-166.7%2018$3.78+709.7%2017$-0.62+43.6%2016$-1.10—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share